The estimated Net Worth of Adam Dubow is at least $1.39 Million dollars as of 30 July 2021. Mr. Dubow owns over 2,466 units of Bristol-Myers Squibb Co stock worth over $669,424 and over the last 6 years he sold BMY stock worth over $722,325. In addition, he makes $0 as Senior Vice President und Chief Compliance Officer and Ethics Officer at Bristol-Myers Squibb Co.
Adam has made over 9 trades of the Bristol-Myers Squibb Co stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 2,466 units of BMY stock worth $167,441 on 30 July 2021.
The largest trade he's ever made was exercising 5,404 units of Bristol-Myers Squibb Co stock on 10 March 2021 worth over $262,580. On average, Adam trades about 2,930 units every 118 days since 2018. As of 30 July 2021 he still owns at least 13,777 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Mr. Dubow stock trades at the bottom of the page.
Adam Dubow serves as Senior Vice President, Chief Compliance Officer and Ethics Officer of the Company. 2013 to 2015 – Vice President and Assistant General Counsel, China, Japan and Intercon Region and EMAC Region 2015 to 2018 – Vice President and Associate General Counsel, Research and Development 2018 to present – Senior Vice President, Chief Compliance and Ethics Officer.
Adam Dubow is 53, he's been the Senior Vice President und Chief Compliance Officer and Ethics Officer of Bristol-Myers Squibb Co since 2018. There are 26 older and 9 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
Adam's mailing address filed with the SEC is 345 Park Ave, New York, NY 10154, USA.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius und Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: